SCHEMBL6132032

SCHEMBL6132032

Cc1ccccc1-c1[nH]nc(N)c1-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
AKT2 P31751 2/20 0.60
KMT2A Q03164 2/20 0.60
RPS6KA3 P51812 1/20 0.56
PIK3CD O00329 1/20 0.51
PIK3CA P42336 1/20 0.51
PIK3CB P42338 1/20 0.51
PIK3CG P48736 1/20 0.51
PRKDC P78527 1/20 0.51
MAP4K4 O95819 1/20 0.49
CSF1R P07333 1/20 0.49
FGFR1 P11362 1/20 0.49
PDGFRA P16234 1/20 0.49
LTK P29376 1/20 0.49
KDR P35968 1/20 0.49
MAPK8 P45983 1/20 0.49
CSNK1A1 P48729 1/20 0.49
LIMK1 P53667 1/20 0.49
CDK5 Q00535 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820038 0.81 MAPK1 (1.00) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL6132028 0.81 MAPK1 (0.67) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL6132023 0.81 MAPK1 (0.67) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL6132022 0.79 MAPK1 (0.80) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL6132033 0.76 MAPK1 (0.70) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL544723 0.75 AKT2 (1.00) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL3877361 0.74 PIK3CD (0.51) MAPK1NPSR1AKT2KMT2APIK3CD
SCHEMBL6116588 0.74 BTK (0.50) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL6132051 0.73 MAPK1 (0.83) MAPK1NPSR1AKT2KMT2ARPS6KA3
SCHEMBL14519404 0.73 MAPK14 (0.47) NPSR1AKT2RPS6KA3PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP disclosed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP disclosed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed